跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ipratropium + salbutamol
首页
药物
ipratropium + salbutamol
ipratropium + salbutamol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PROPELLANT-FREE AEROSOL FORMULATION FOR INHALATION
US 2010056559 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2006
US
3 件公开
Crystal structure
US 6875449 B1
申请人: GLAXO WELLCOME INC
优先权: 1999
US
Pharmaceutical Composition Comprising an Isomer of Betamimetic Agent and an Anti-Cholinergic Agent
US 2007264202 A1
申请人: CIPLA LTD
优先权: 2004
US
Oral treating agent for treating chronic obstructive disease of lung (COPD) containing ipratropium bromide and salbutamol
CN 1682724 A
申请人: YANG RUOCHUAN
优先权: 2005
CN
AEROSOL FORMULATION
US 2010144784 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2006
US
Inhalation powder spray for treating respiratory diseases such as chronic obstructive pulmonary disease and asthma
CN 101428011 A
申请人: HUSHAN LI
优先权: 2008
CN
Medicinal composition taking ipratropium bromide and salbutamol as main active ingredients
CN 101849939 A
申请人: BEIJING LILESHENG PHARMACEUTICAL CO LTD
优先权: 2009
CN
Preparation method of compound ipratropium bromide solution for inhalation
CN 114699393 A
申请人: CHENGDU PUTH PHARMACEUTICAL CO LTD
优先权: 2022
CN
Atomizing agent based on G-type alginate oligosaccharide, atomizing agent concentrated solution and preparation method and application thereof
CN 115671291 A
申请人: SHENZHEN SANLIN BIOTECHNOLOGY CO LTD
优先权: 2022
CN
Atomized liquid containing diatom and application thereof
CN 118717816 A
申请人: UNIV CHONGQING
优先权: 2023
CN
药物
反馈